Incyte
INCY
#1194
Rank
HK$156.92 B
Marketcap
HK$788.53
Share price
-0.47%
Change (1 day)
37.13%
Change (1 year)

Revenue for Incyte (INCY)

Revenue in 2024: HK$32.92 Billion

According to Incyte's latest financial reports the company's current revenue (TTM ) is HK$37.63 Billion. In 2024 the company made a revenue of HK$32.92 Billion an increase over the revenue in the year 2023 that were of HK$28.86 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Incyte from 1996 to 2024

Annual revenue

Year Revenue Change
2024HK$32.92 B14.08%
2023HK$28.86 B8.82%
2022HK$26.52 B13.9%
2021HK$23.28 B12.64%
2020HK$20.67 B22.96%
2019HK$16.81 B14.09%
2018HK$14.73 B22.78%
2017HK$12.00 B39.98%
2016HK$8.57 B46.77%
2015HK$5.84 B47.25%
2014HK$3.96 B44.14%
2013HK$2.75 B19.54%
2012HK$2.30 B213.86%
2011HK$0.73 B-44.51%
2010HK$1.32 B1740.27%
2009HK$71.83 M137.15%
2008HK$30.29 M-88.72%
2007HK$0.26 B24.9%
2006HK$0.21 B253.39%
2005HK$60.84 M-27.3%
2004HK$83.68 M-77.07%
2003HK$0.36 B-53.94%
2002HK$0.79 B-53.65%
2001HK$1.70 B12.9%
2000HK$1.51 B24.12%
1999HK$1.22 B16.82%
1998HK$1.04 B51.08%
1997HK$0.69 B117.45%
1996HK$0.31 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
HK$443.14 B 1,077.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$490.93 B 1,204.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$464.61 B 1,134.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$281.26 B 647.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$1.96 B-94.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
HK$1.43 B-96.19%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
HK$0.59 B-98.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
HK$0.73 B-98.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
HK$3.11 B-91.73%๐Ÿ‡บ๐Ÿ‡ธ USA